(PharmaNewsWire.Com, June 10, 2018 ) The breast implants market is classified by product and application. The breast implants market is segmented by product into silicone implants and saline implants. Based on the application, the breast implants market can be segmented into reconstructive surgery and cosmetic surgery. Geographically, the market for breast implants is categorized as North America, Europe, Asia Pacific (APC), Middle East and Africa (MEA) and South and Central America (S&CAM).
Breast augmentation or breast implant surgery is a progressively popular procedure across the globe. With the FDA approval for advanced qualities in silicone and saline implants, the procedure has become safer and highly effective in the past few years. Breast lift and breast implant both surgeries require high level of surgical expertise. The costs for the two procedures slightly diverge. In some cases, the plastic surgeon advises a combination of both the procedures for more comprehensive outcome. The new product launches & FDA approvals, technological advancements, and high prevalence of breast cancer cases are expected to boost the growth of breast implants market in the coming years. Also, the companies operating the breast implants market have been investing substantial time and amount in research and development activities, through which better technologies can be introduced in the market. Such activities by the manufacturers are also expected to propel the market growth in the coming years.
The breast implants market is estimated to grow at a CAGR of 4.3% during the forecast period from 2018 to 2025. The market for breast implants is estimated to reach US$ 1,981.2 Mn by 2025. The market for breast implants is witnessing a healthy growth rate during the previous years and is expected to witness similar trend in the coming years. The companies operating in the market of breast implants provide their products and services for applications such as reconstructive surgery and cosmetic surgery. With constant R&D activities, the companies have been focusing towards developing advanced products in breast implants market. Various players have been upgrading their product portfolio by applying for approvals. With expansion activities, companies are focusing towards strengthening their customer base by providing services to varied applications.
The market for breast implants is well established in North America region, especially in the U.S and Canada. Companies are engaging in expansion activities in order to strengthen their customer presence in the region. For instance, in December 2016, Sientra, Inc. received U.S. Food and Drug Administration (FDA) pre-market supplement approval (PMA) for four new breast implant styles. Such approvals are expected to bolster the market growth in the coming years.
The major players operating in the market of breast implants market include Allergan Plc, Mentor Worldwide LLC, Sientra Inc., GC Aesthetics PLC, POLYTECH Health & Aesthetics GmbH, Hansbiomed Co. Ltd., Ideal Implant Incorporated, Guangzhou Wanhe Plastic Materials Co., Ltd., Establishment Labs S.A., Groupe Sebbin SAS among others. About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: